Drug Database
AC

aclidinium bromide + formoterol (Eklira+ formoterol / Duaklir / LAS 40464)

✓ Approved

Kyorin · ADRB2 · 小分子

什么是 aclidinium bromide + formoterol?

aclidinium bromide + formoterol 是一种小分子,由Kyorin研发。该药已获批,用于治疗相关适应症,给药途径:Inhaled。

药物档案

商品名Eklira+ formoterol, Duaklir, LAS 40464
公司Kyorin
药物类别小分子
分子靶点ADRB2, CHRM3
给药途径Inhaled
状态Approved

作用机制

分子靶点

aclidinium bromide + formoterol 作用于 2 个分子靶点:

ADRB2adrenoceptor beta 2 (B2AR, ARB2)
CHRM3cholinergic receptor muscarinic 3 (HM3, PBS)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

aclidinium bromide + formoterol 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Respiratory, thoracic and mediastinal disordersChronic obstructive pulmonary disease✓ Approved

相关研究文献

PubMedExpert review of pharmacoeconomics & outcomes research2026-11-18

Cost-effectiveness of Umeclidinium/Vilanterol versus aclidinium monotherapy for symptomatic COPD in Colombia: a lifetime Markov Model.

Buendía Jefferson Antonio JA

To evaluate the lifetime cost-effectiveness of once-daily umeclidinium/vilanterol (UMEC/VI) versus twice-daily aclidinium monotherapy for symptomatic chronic obstructive pulmonary disease (COPD) in Colombia. A lifetime Markov model with monthly cycles simulated moderate-to-very-severe COPD in a cohort aged 65 years, incorporating age- and severity-specific background mortality and a 12% case-fatality probability after each severe exacerbation. Comparative efficacy came from a published network meta-analysis; comparator exacerbation probabilities were derived on the rate scale. Costs and quality-adjusted life-years (QALYs) were discounted at 5% annually. Deterministic, scenario, and probabilistic sensitivity analyses were performed. UMEC/VI yielded 8.108 QALYs at US$24,956 per patient versus 6.312 QALYs and US$29,994 for aclidinium (incremental 1.796 QALYs; US$5,038 saved), making UMEC/VI dominant (net monetary benefit US$14,341). UMEC/VI was dominant in 94.7% and cost-effective in 98.6% of probabilistic simulations. Without its exacerbation benefit, UMEC/VI was not cost-effective (net monetary benefit -US$859). UMEC/VI is a high-value COPD maintenance therapy in Colombia, driven by exacerbation reduction rather than drug pricing and conditional on persistence of its clinical benefit.

PMID 43048953
阅读全文 →
PubMedCrystal growth & design2026-11-18

Epimer-Dependent Solid-State Landscapes of Trospium and Exotrospium Halide Salts.

Babor Martin M, Spingler Bernhard B, Šimek Josef J, Čejka Jan J et al.

Trospium (TR) and exotrospium (ETR) form a closely related epimeric pair of quaternary ammonium compounds, differing only in the stereochemistry of the tropane ring system. While the solid-state chemistry of trospium has been studied mainly for its chloride salt, no crystal structures of exotrospium salts have previously been reported. Here, we investigate the epimer-dependent solid-state landscapes of TR and ETR across the halide series, using matched salt forms to distinguish the effects of counterion selection from those of stereochemical inversion. Two new TR salts and three new ETR salts were prepared and structurally characterized by single-crystal X-ray diffraction, supported by crystal-packing comparison, hydrogen-bond propensity analysis, lattice-energy calculations, morphology prediction, and CSD-Particle surface analysis. Despite their close molecular similarity, TR and ETR display markedly different solid-state behavior. TR forms anhydrous chloride, bromide, and iodide salts stabilized by direct charge-assisted O-H···halide interactions, whereas ETR forms isostructural chloride and bromide dihydrates, with only the iodide obtained as an anhydrate. These differences are reflected in molecular conformation, crystal packing, hydration behavior, predicted crystal habit, and surface descriptors. The results show that epimerization can substantially alter both bulk and surface features of pharmaceutical molecular salts and demonstrate the value of combining structural comparison with particle-level descriptors when evaluating related solid forms.

PMID 43048678
阅读全文 →
PubMedChemMedChem2026-11-18

Synthesis, Structure, and In Vivo Evaluation of Analgesic Activity of N-propargyl-2-methyl-trans-decahydroquinolin-4-one Oximes.

Dubrovskiy Vladislav A VA, Starodubtseva Alena A AA, Shoibek Karina S KS, Sosin Vadim G VG et al.

Two new N-propargyl derivatives of trans-2-methyl-decahydroquinolin-4-one and their corresponding oximes were synthesized from individual trans-epimers via N-alkylation with propargyl bromide followed by oximation. A solvent-minimized mechanochemical protocol enabled rapid conversion of the ketones into the target oximes within 3-5 min and provided isolated yields of about 96%, while a solution-phase control using the same base required 5 h. Single-crystal X-ray diffraction confirmed the structures and stereochemistry of all four compounds and showed that oximation proceeds stereoselectively to give exclusively E-configured products while preserving the trans-fused bicyclic framework. Biological evaluation included an egg albumin denaturation assay, the hot plate test in mice, and acute oral toxicity studies. Both ketones and oximes showed marked protein-stabilizing activity, with no consistent effect of oximation or C2 methyl-group orientation in this assay. All four compounds showed increases in mean nociceptive-response latency at selected time points, while the oximes, particularly those containing an axial methyl group, showed higher mean responses than the corresponding ketones at several early and intermediate time points. Acute oral toxicity studies classified all four compounds as toxicity class IV, with LD50 values of approximately 1048-1295 mg/kg. Thus, oximation retained the low acute-toxicity profile of the N-propargylated ketones while preserving biological activity.

PMID 43046533
阅读全文 →
PubMedAnalytical chemistry2026-11-18

Multiplex Isotope Tagging-Electromembrane Extraction of Metabolites with Diverse Polarities.

Liu Yangyang Y, Chen Li L, Ma Shengtao S, Pedersen-Bjergaard Stig S et al.

In this work, a multiplex isotope tagging-electromembrane extraction (MIT-EME) strategy was proposed to address two critical drawbacks of conventional EME in metabolite analysis: failure to simultaneously extract polar and non-polar metabolites, and limited analytical throughput. Specifically, seven carnitines covering the hydrophobicity (log P) range of -0.5 to 3.2 were selected as model analytes, and were studied in human serum samples. The carnitines were labeled with p-dimethylaminophenacyl (DmPA) bromide and its two isotopic analogues for sample encoding. Labeled samples were then pooled and subjected to EME and liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis. The labeling increased the lipophilicity of the carnitines (0.9 ≤ log P ≤ 4.6), thereby increasing the partition coefficient by more than two orders of magnitude and the transmembrane flux by up to 43.9-fold, ultimately enabling efficient simultaneous extraction of polar and non-polar carnitines with recoveries of 62-95%. The MIT-EME-LC-MS/MS method provided satisfactory limits of detection (0.02-0.09 ng mL-1), accuracy (90-113%), precision (≤14%), and matrix effects (90-107%). Benefiting from isotopic multiplexing, samples were pooled and analyzed in a single LC-MS/MS run, and achieved the synchronous analysis of three serum samples. The method was applied to serum samples from 100 hyperuricemia patients and 200 healthy individuals, and obvious intergroup differences of serum carnitines were observed. The strategy developed in this study provides a powerful approach for large-scale metabolomics analysis.

PMID 43046476
阅读全文 →
PubMedRSC medicinal chemistry2026-11-18

Impurity-driven lead discovery from raltegravir: synthesis, characterization, anticancer evaluation, and mechanistic insights.

Prasad Satram Sivakrishna S, Xia Hong-Ying HY, Kankala Ranjith Kumar RK, Tiwari Pushpendra P et al.

Pharmaceutical process-related impurities are generally regarded as undesirable by-products, yet their structural diversity may provide an underexplored source of bioactive scaffolds for medicinal chemistry. Herein, we demonstrate an impurity-driven lead discovery strategy using the HIV integrase inhibitor raltegravir as a starting point. Raltegravir impurities A-G were systematically synthesized and characterized, involving the development of new synthetic methodologies for Imp-B, Imp-D, and Imp-F/G, a scalable and improved route for Imp-A, and optimized or alternative procedures for Imp-C and Imp-E. In particular, cost-effective N-methylation using trimethylsulfoxonium bromide enabled efficient and scalable access to key intermediates and Imp-A, while optimized isolation procedures afforded high-purity impurities suitable for biological evaluation. Screening of these impurities against 4T1 murine mammary carcinoma cells revealed pronounced antiproliferative activity for Imp-A compared with raltegravir and the other impurities, identifying it as the most promising member of the series. Importantly, this represents the first systematic biological evaluation of the pharmacopeial raltegravir impurity series within an impurity-driven lead discovery framework. Structure-activity analysis indicated that removal of the bulky oxadiazole-carboxamide terminus while retaining the 4-fluorobenzyl-substituted hydroxypyrimidinone scaffold and accessible amino functionality favored antiproliferative activity. Further mechanistic investigations indicated that Imp-A induces concentration-dependent cell death as confirmed by live/dead staining. This effect was associated with elevated intracellular reactive oxygen species (ROS) levels and disruption of mitochondrial membrane potential, suggesting ROS-mediated mitochondrial dysfunction as a key mechanism. Collectively, these findings establish raltegravir impurities as a valuable chemical space for lead discovery and identify Imp-A as a promising scaffold for further medicinal chemistry optimization, while demonstrating the broader potential of pharmaceutical impurity profiling as a complementary strategy for bioactive lead identification.

PMID 43048690
阅读全文 →
PubMedDalton transactions (Cambridge, England : 2003)2026-11-17

A systematic DFT study of oxidative addition to copper(I): mechanistic diversity and the role of ligands, solvents, and substrates.

Gómez-Mudarra Francisco A FA, Aullón Gabriel G, Jover Jesús J

Oxidative addition (OA) of organic halides to copper(I) complexes remains a mechanistically complex and comparatively underexplored step in cross-coupling catalysis, particularly when compared to the well-established reactivity of palladium systems. In this work, a systematic computational investigation of OA processes at a copper(I) model fragment has been carried out by means of density functional theory (DFT), encompassing more than 300 activation barriers for a wide range of N-donor ligands, solvents, and substrates. Four distinct mechanistic pathways: concerted cyclic (CC), nucleophilic substitution (SN), halogen atom transfer (XAT), and single electron transfer (SET), have been explored for both alkyl (ethyl) and aryl (phenyl) bromide substrates. The computed results indicate that the preferred OA mechanism is primarily dictated by the nature of the substrate. Ethyl bromide preferentially follows the SN pathway, whereas phenyl bromide predominantly undergoes activation through a CC mechanism. Additional calculations for secondary and tertiary alkyl bromides suggest that increasing substitution at the carbon undergoing C-Br cleavage can alter the relative order of SN and XAT pathways. Ligand effects play a crucial role in modulating reactivity, with increased denticity and electron-donating ability generally leading to lower activation barriers, while steric hindrance near the metal center is detrimental to OA. The analysis of transition state geometries and bonding descriptors reveals correlations between activation barriers and the extent of C-Br bond weakening and Cu-substrate interaction development, particularly for phenyl bromide activation through the CC pathway. Complementary descriptor-based models identify the electronic properties of the copper complex and the structural reorganization required for activation as useful predictors of barriers for the principal pathways examined. Solvent effects have been evaluated, showing that polar media significantly stabilize pathways involving charge separation, particularly in the case of SN and SET mechanisms, with solvents such as N,N-dimethylformamide providing a notable reduction in the corresponding activation barriers. In contrast, the CC and XAT pathways appear to be comparatively insensitive to the nature of the solvent. Overall, this study provides a mechanistic framework for copper(I)-mediated oxidative addition that connects substrate-dependent pathway preferences with ligand and solvent effects, transition state structure, and electronic and structural reorganization. These relationships can help guide the design of catalytic systems based on earth-abundant metals.

PMID 43041185
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多aclidinium bromide + formoterol